Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen.

To investigate the role of Stat3 (signal transducer and activator of transcription-3) in neoplastic transformation by the Large Tumor antigen of Simian Virus 40 (TAg), murine fibroblasts were rendered deficient in Stat3 activity through expression of a Stat3-specific siRNA or a Cre-loxP recombination system. The results demonstrate that growth rate, formation of foci overgrowing a monolayer of normal cells and colony formation in soft agar were dramatically reduced in Stat3-deficient cells. In addition, TAg expression led to increased Stat3 tyrosine phosphorylation, DNA binding, and transcriptional activity, suggesting that Stat3 is required for TAg-mediated neoplasia. Stat3 activation was prevented by blocking the binding of TAg to pRb (retinoblastoma-susceptibility gene product), whereas genetic ablation of pRb increased Stat3 activity, suggesting that pRb inactivation by TAg might be responsible for the observed Stat3 activation. Stat3 activation by TAg was suppressed after inhibition of c-Src, JAKs or the insulin-like growth factor receptor. On the other hand, targeted disruption of the Fer kinase or pharmacological inhibition of Abl had no effect. Inhibition of Src activity led to Stat3 down-regulation as well as apoptosis of sparsely growing, TAg-transformed cells. However, Src inhibition was relatively ineffective in confluent cells, consistent with previous results indicating that cell to cell adhesion activates Stat3 by a Src-independent mechanism. Direct Stat3 inhibition on the other hand induced apoptosis very effectively in confluent cells, which could have significant therapeutic implications. Taken together, our results suggest that Stat3 is an important component of a pathway emanating from TAg and leading to neoplastic conversion.

[1]  A. Vultur,et al.  Transfection techniques affecting Stat3 activity levels. , 2005, Analytical biochemistry.

[2]  D. Kaplan,et al.  SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions. , 2004, Molecular cancer research : MCR.

[3]  C. Daniels,et al.  Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. , 2004, The Journal of clinical investigation.

[4]  J. Turkson,et al.  Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells , 2004, Oncogene.

[5]  J. Turkson,et al.  Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. , 2004, Molecular cancer therapeutics.

[6]  Hua Yu,et al.  The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.

[7]  M. Schaller,et al.  FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.

[8]  Rakesh Nagarajan,et al.  Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway , 2003, Oncogene.

[9]  E. Surmacz,et al.  Role of the IGF‐I receptor in the regulation of cell–cell adhesion: Implications in cancer development and progression , 2003, Journal of cellular physiology.

[10]  Jean Y. J. Wang,et al.  Coordinated regulation of life and death by RB , 2003, Nature Reviews Cancer.

[11]  Hua Yu,et al.  Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells , 2002, Oncogene.

[12]  R. Jove,et al.  Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin. , 2002, Cancer research.

[13]  B. Rothen‐Rutishauser,et al.  Dynamics of Tight and Adherens Junctions Under EGTA Treatment , 2002, The Journal of Membrane Biology.

[14]  J. Pipas,et al.  T Antigens of Simian Virus 40: Molecular Chaperones for Viral Replication and Tumorigenesis , 2002, Microbiology and Molecular Biology Reviews.

[15]  Jiayuh Lin,et al.  p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3 , 2002, Oncogene.

[16]  Rosalie C Sears,et al.  Signaling Networks That Link Cell Proliferation and Cell Fate* , 2002, The Journal of Biological Chemistry.

[17]  P. Greer.  Closing in on the biological functions of fps/fes and fer , 2002, Nature Reviews Molecular Cell Biology.

[18]  C. Ramana,et al.  The Role of Hsp90N, a New Member of the Hsp90 Family, in Signal Transduction and Neoplastic Transformation* , 2002, The Journal of Biological Chemistry.

[19]  Jiayuh Lin,et al.  Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells. , 2002, Cancer research.

[20]  J. Turkson,et al.  Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation* , 2001, The Journal of Biological Chemistry.

[21]  J. Miyazaki,et al.  Tissue-Specific Autoregulation of thestat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells , 2001, Molecular and Cellular Biology.

[22]  T. Roberts,et al.  Simian Virus 40 Large Tumor Antigen Modulates the Raf Signaling Pathway* , 2001, The Journal of Biological Chemistry.

[23]  Hua Yu,et al.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.

[24]  B. Elliott,et al.  Co-operative Effect of c-Src Tyrosine Kinase and Stat3 in Activation of Hepatocyte Growth Factor Expression in Mammary Carcinoma Cells* , 2001, The Journal of Biological Chemistry.

[25]  N. Dyson,et al.  p107 and p130: versatile proteins with interesting pockets. , 2001, Experimental cell research.

[26]  D. Link,et al.  STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. , 2001, Immunity.

[27]  J. Turkson,et al.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. , 2001, The Journal of clinical investigation.

[28]  T. Jacks,et al.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. , 2000, Genes & development.

[29]  J. Turkson,et al.  Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity* , 2000, The Journal of Biological Chemistry.

[30]  S. Akira.  Roles of STAT3 defined by tissue-specific gene targeting , 2000, Oncogene.

[31]  R. Jove,et al.  Activation of Stat3 preassembled with platelet-derived growth factor β receptors requires Src kinase activity , 2000, Oncogene.

[32]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[34]  Monilola A. Olayioye,et al.  ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases* , 1999, The Journal of Biological Chemistry.

[35]  M. Vignais,et al.  Distinct Mechanisms of Activation of Stat1 and Stat3 by Platelet-Derived Growth Factor Receptor in a Cell-Free System , 1999, Molecular and Cellular Biology.

[36]  J. Turkson,et al.  Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation , 1998, Molecular and Cellular Biology.

[37]  J. Darnell,et al.  Stat3 Activation Is Required for Cellular Transformation by v-src , 1998, Molecular and Cellular Biology.

[38]  J. Decaprio,et al.  The J Domain of Simian Virus 40 Large T Antigen Is Required To Functionally Inactivate RB Family Proteins , 1998, Molecular and Cellular Biology.

[39]  G. Ramponi,et al.  c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. , 1997, Biochemical and biophysical research communications.

[40]  S. Hanks,et al.  Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. , 1996, Biochemical and biophysical research communications.

[41]  M. Vignais,et al.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins , 1996, Molecular and cellular biology.

[42]  R. Baserga,et al.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen , 1995, Molecular and cellular biology.

[43]  R. Jove,et al.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.

[44]  J. Swantek,et al.  An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum. , 1994, Oncogene.

[45]  J. Johnston,et al.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2 , 1994, Nature.

[46]  E. Liu,et al.  Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells , 1994, Nature.

[47]  D. Coppola,et al.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts , 1994, Molecular and cellular biology.

[48]  D. Tedesco,et al.  Limits of transforming competence of SV40 nuclear and cytoplasmic large T mutants with altered Rb binding sequences. , 1993, Oncogene.

[49]  T. Yamamoto,et al.  CSK: a protein-tyrosine kinase involved in regulation of src family kinases. , 1991, The Journal of biological chemistry.

[50]  B. Cochran,et al.  The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter. , 1990, The EMBO journal.

[51]  F. Ciardiello,et al.  Differential growth factor expression in transformed mouse NIH‐3T3 cells , 1990, Journal of cellular biochemistry.

[52]  F. Traganos,et al.  Growth of immortal simian virus 40 tsA-transformed human fibroblasts is temperature dependent , 1989, Molecular and cellular biology.

[53]  L. Raptis,et al.  Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts , 1985, Molecular and cellular biology.

[54]  B. Ozanne,et al.  Polyoma virus-transformed cells produce transforming growth factor(s) and grow in serum-free medium. , 1982, Virology.

[55]  Jeffrey M. Trimarchi,et al.  Transcription: Sibling rivalry in the E2F family , 2002, Nature Reviews Molecular Cell Biology.

[56]  D. Levy,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[57]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[58]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.